Laboratorios Davur

Laboratorios Davur is a Spanish pharmaceutical company specializing in the development, manufacturing, and commercialization of generic medicines. Founded in 1975, the company established a significant presence in the Spanish healthcare market by providing a broad portfolio of affordable therapeutic options across multiple medical fields. In 2004, Laboratorios Davur was integrated into Teva Pharmaceutical Industries following Teva's acquisition of the Sicor Group. Today, it operates as a key subsidiary within Teva's Spanish operations, focusing on essential medications for cardiovascular, central nervous system, and gastrointestinal disorders. The company is recognized for its commitment to high-quality manufacturing standards and its role in supporting the sustainability of the Spanish national health system.